Skip to content
EU’s plan for new pharma regulations poses challenges for industry, say experts at BIO convention
A proposal to provide the first overhaul of European Union pharma regulation in 20 years takes some positive steps but would still leave a […]
Latest News
How the U.S. and Asia Pacific are collaborating to grow biotech innovation
Asian-Pacific countries and the United States are promoting biotech development through special programs to encourage their domestic industry combined with concerted efforts to attract
How the U.S. and Asia Pacific are collaborating to grow biotech innovation Read More »
Lift off for BIO International Convention 2023
It’s official: The 2023 BIO International Convention is open! The four-day event includes 150 sessions featuring 800 speakers. An incredible lineup of experts will
Lift off for BIO International Convention 2023 Read More »
Medicare confirms registry requirement for new class of Alzheimer’s drugs
A new class of Alzheimer’s drugs will be available to patients on Medicare – but only if the medicine has received “traditional approval” and
Medicare confirms registry requirement for new class of Alzheimer’s drugs Read More »
Film festival kicks off BIO International Convention
Up-close-and-personal stories of patients with a range of disorders will be broadcast throughout this week at the Biotechnology Innovation Organization (BIO) International Convention in
Film festival kicks off BIO International Convention Read More »
The U.S. Codex Office needs more funding – here’s why
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other biotechnology organizations sent a letter to congressional leaders calling for more
The U.S. Codex Office needs more funding – here’s why Read More »
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected,
IRA means 40% reduction in new drugs over 10 years, report finds Read More »
FDA approves Pfizer’s RSV vaccine for adults over age 60
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on
FDA approves Pfizer’s RSV vaccine for adults over age 60 Read More »
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was
BIO-backed bills that would support startups passed by House Read More »
Breaking down the EU Pharmaceutical Package: What U.S. companies should know
The EU Pharmaceutical Package is a series of legislative proposals that aims to, among other things, improve access, affordability, and availability of medicinal products
Breaking down the EU Pharmaceutical Package: What U.S. companies should know Read More »